Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder J.H. Whitney Equity Partners V Sells 919,389 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $8.00, for a total value of $7,355,112.00. Following the transaction, the insider directly owned 12,531,158 shares in the company, valued at approximately $100,249,264. The trade was a 6.84% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The stock was sold at an average price of $6.24, for a total value of $36,455,577.60.

Aveanna Healthcare Trading Up 1.9%

NASDAQ AVAH opened at $8.64 on Friday. The firm has a market capitalization of $1.88 billion, a P/E ratio of 7.32, a PEG ratio of 0.88 and a beta of 1.93. The business has a fifty day simple moving average of $7.14 and a 200 day simple moving average of $7.58. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.73 and a 12 month high of $10.32. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare’s quarterly revenue was up 15.9% compared to the same quarter last year. On average, analysts predict that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current fiscal year.

Institutional Trading of Aveanna Healthcare

Several hedge funds have recently added to or reduced their stakes in the stock. AustralianSuper Pty Ltd purchased a new position in Aveanna Healthcare in the third quarter valued at about $15,743,000. Vanguard Group Inc. increased its stake in shares of Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after purchasing an additional 1,535,351 shares during the last quarter. Millennium Management LLC raised its holdings in shares of Aveanna Healthcare by 1,007.1% in the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after purchasing an additional 1,014,030 shares during the period. Nuveen LLC raised its holdings in shares of Aveanna Healthcare by 135.9% in the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after purchasing an additional 905,316 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its stake in Aveanna Healthcare by 451.3% in the third quarter. Arrowstreet Capital Limited Partnership now owns 959,488 shares of the company’s stock valued at $8,511,000 after purchasing an additional 785,452 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

AVAH has been the subject of a number of recent analyst reports. Barclays reduced their price objective on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research report on Monday, May 18th. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a research note on Wednesday, June 3rd. Truist Financial upped their target price on Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a report on Wednesday, May 20th. BMO Capital Markets decreased their price target on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 20th. Finally, Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $10.00 to $11.00 in a report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Aveanna Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.